Compare NPO & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPO | GRFS |
|---|---|---|
| Founded | 2002 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.2B |
| IPO Year | 2002 | 2008 |
| Metric | NPO | GRFS |
|---|---|---|
| Price | $300.61 | $7.57 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $278.33 | $10.15 |
| AVG Volume (30 Days) | 126.3K | ★ 371.0K |
| Earning Date | 05-05-2026 | 07-28-2022 |
| Dividend Yield | 0.46% | ★ 1.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.55 | N/A |
| Revenue | ★ $1,532,000,000.00 | N/A |
| Revenue This Year | $12.31 | $4.49 |
| Revenue Next Year | $6.39 | $6.42 |
| P/E Ratio | $117.84 | ★ $18.67 |
| Revenue Growth | ★ 16.98 | N/A |
| 52 Week Low | $202.00 | $6.96 |
| 52 Week High | $390.42 | $10.23 |
| Indicator | NPO | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 35.99 | 42.77 |
| Support Level | $259.63 | $7.50 |
| Resistance Level | $286.35 | $7.73 |
| Average True Range (ATR) | 9.73 | 0.14 |
| MACD | -0.27 | -0.04 |
| Stochastic Oscillator | 2.30 | 9.26 |
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through two segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies, which manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.